Christopher Eden, Ph.D

Christopher Eden, Ph.D has extensive work experience in the field of bio-technology and business development. Christopher is currently serving as the Senior Director of Business Development at Panome Bio, where they provide pharmaceutical companies access to advanced capabilities in Next-Generation Metabolomics and Proteomics. Prior to this, they worked as the Director of Business Development at M2GEN.

In their previous roles, Dr. Eden held positions at Canopy Biosciences as the Director of Business Development, where they aligned pharmaceutical companies and researchers with advanced NGS and spatial proteomic technologies for optimizing patient treatments. Christopher also served as the Product Manager for Nanostring Oncology Service, where they managed the NanoString oncology service portfolio and increased its awareness and profitability. Before that, they worked as a Product Manager Oncology at Horizon Discovery, where they provided accurate preclinical models for clinical trials and offered market research data and expert consultation in oncology.

Dr. Eden also has experience in sales, as they worked as an Advanced Imaging Sales Specialist at Nikon Instruments. Christopher tailored advanced imaging systems to meet the needs of clinicians and clinical researchers, optimizing patient diagnoses. Additionally, they worked at St. Jude Children's Research Hospital - ALSAC as a Molecular Oncology Research Scientist, where they developed novel brain tumor models for preclinical screening and conducted drug studies on various brain tumors. Christopher also served as a Senior Research Technologist, managing histological processing, and as a Research Technologist, producing gene expression data for clients.

Throughout their career, Dr. Eden has demonstrated exceptional sales performance, built multi-million-dollar territories, and consistently achieved top sales recognition. Christopher is skilled in building relationships with key opinion leaders and decision makers, as well as providing strategic planning and consultation in the field of bio-technology.

Christopher Eden, Ph.D completed their Doctor of Philosophy (Ph.D.) in Cancer Biology from The University of Memphis between 2008 and 2014. Prior to that, they earned a Master of Science Degree in Biology from Murray State University, specializing in Biology, General, from 2002 to 2004. Finally, they obtained their Bachelor of Science (B.S.) in Biology/Biological Sciences, General from Murray State University. The exact start and end years for their Bachelor's degree are not provided.